PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Biovet JSC's PE Ratio without NRI is 0.00. Biovet JSC's 5-Year EBITDA growth rate is 27.50%. Therefore, Biovet JSC's PEG Ratio for today is 0.00.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Biovet JSC's PEG Ratio or its related term are showing as below:
LTS:0III'
s PEG Ratio Range Over the Past 10 Years
Min: 0.21 Med: 1.98 Max: 2.17
Current: 0.21
During the past 8 years, Biovet JSC's highest PEG Ratio was 2.17. The lowest was 0.21. And the median was 1.98.
LTS:0III's PEG Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.75
vs LTS:0III: 0.21
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Biovet JSC (LTS:0III) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Biovet JSC PEG Ratio Related Terms
Biovet JSC PEG Ratio Historical Data
* Premium members only.
The historical data trend for Biovet JSC's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0III vs ADMP, AGRX, BUDZ: PEG Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Biovet JSC's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biovet JSC PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Biovet JSC's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Biovet JSC's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Biovet JSC (LTS:0III) has a PEG Ratio of 0.00 as of Jul. 06, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Biovet JSC and its competitors. Over the past decade, Biovet JSC's PEG Ratio has ranged from 0.21 to 2.17.
Is Biovet JSC's PEG Ratio too high?
Biovet JSC's current PEG Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 2.17.
How does Biovet JSC's PEG Ratio compare to ADMP and AGRX?
Biovet JSC's PEG Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median PEG Ratio is 1.75. Historically, Biovet JSC's own PEG Ratio has ranged from 0.21 to 2.17 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.75, based on 349 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Biovet JSC and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biovet JSC's current PEG Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current PEG Ratio of 0.00. The current PEG Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current PEG Ratio is 0.00 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0III has been successfully added to your 